A recent report from the Private Healthcare Information Network (PHIN) highlights rising admissions for cancer care across London’s independent sector – reinforcing the critical role private providers play in delivering timely oncology services. The report identifies that London has seen the biggest rise in cancer admissions since 2022, compared with other regions across the UK.
With 40% of London’s private healthcare activity taking place within the Harley Street Health District, the findings affirm the District’s position as one of the world’s leading destinations for cancer diagnosis and treatment. The majority of these admissions are funded through private medical insurance (PMI), underlining the growing importance of employer and individual cover in enabling access to specialist care.
Major providers continue to invest. HCA Healthcare UK remains the largest independent provider of cancer care, including The Harley Street Clinic and Leaders in Oncology Care (LOC), both based in the District. Two decades ago, LOC was founded on a simple but powerful idea: that cancer care could be both world-class and genuinely personal. Today, that vision has grown into a network delivering highly personalised oncology treatment.
Innovation is also visible at The London Clinic, which recently introduced pioneering blood cancer treatments, including advanced therapies for myeloma — further strengthening the District’s specialist offer.
Looking ahead, Cleveland Clinic London has announced a new dedicated cancer centre at 40 Grosvenor Place, due for completion by the end of 2027 — another significant expansion of private oncology capacity in central London.
These developments sit alongside the ambitions of the NHS Cancer Strategy, a bold ten-year plan focused on prevention, earlier diagnosis, faster treatment, improved survival and reducing inequalities. With a target that three-quarters of people diagnosed with cancer will survive five years or more by 2035, the strategy underscores the scale of the national challenge.
Together, public ambition and private sector investment signal a shared commitment: advancing cancer care across the whole pathway – from detection and diagnosis through to treatment, recovery and long-term health.
Click here to answer our poll question: Where is the private sector best placed to support NHS cancer strategy goals?
